Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.75 - $1.31 $747 - $1,306
-997 Reduced 0.37%
267,269 $331,000
Q1 2024

May 13, 2024

BUY
$0.79 - $1.14 $6,409 - $9,248
8,113 Added 3.12%
268,266 $257,000
Q4 2023

Feb 13, 2024

BUY
$1.02 - $2.57 $10,567 - $26,625
10,360 Added 4.15%
260,153 $278,000
Q3 2023

Nov 13, 2023

BUY
$2.52 - $5.69 $629,478 - $1.42 Million
249,793 New
249,793 $639,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $44.8M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.